department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Nanoscope Therapeutics Inc · pharmadog

PUBLIC COMPANY

Nanoscope Therapeutics Inc

updated 1mo ago

community read0 votes

pipeline

2

marketed

0

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Preclinical1Phase 3

sonpiretigene isteparvovec

Retinitis Pigmentosa (Retinitis)

Geographic Atrophy

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Nanoscope Therapeutics Inc jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

Ophthalmology2 AMD1

mentioned in

0news items

entity-linker matched

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

—A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injectionenrolling by invitationn=11
—Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Studyactive not recruitingn=18
—A Prospective Observational Study to Assess the Reliability and Validity of the MLSDTrecruitingn=30
—Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Studyactive not recruitingn=6
phase2Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]completedn=27
—Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDTcompletedn=35
phase2Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Diseasecompletedn=6